Eye drop container delivery: A source of response variation?

Ophthalmic and Physiological Optics

Volumn 17, Issue 3, 1997, Pages 196-204

  German, Emma J ^a   Hurst, Mark A ^a   Wood, Diana ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; MYDRIATIC AGENT;

ARTICLE; CONTAINER; DRUG INSTILLATION; DRUG RESPONSE; HUMAN; INTRAOCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL;

DRUG PACKAGING; OPHTHALMIC SOLUTIONS; SURFACE TENSION; VISCOSITY;

EID: 0031005888     PISSN: 02755408     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0275-5408(96)00084-1     Document Type: Article

References (41)

1. Barbur, J. L., Hess, R. F. and Pinney, H. D. (1994). Pupillary function in human amblyopia. Ophthal. Physiol. Opt., 14, 139-149.
2. Benjamin, W. J. and Hill, R. M. (1983). Human tears: osmotic characteristics. Invest. Ophthalmol. Vis. Sci., 24, 1624-1626.
3. Berg, A. M., Anderson, J. J., Chipkin, S. R., Lee, V. K., Skinner, M., Cohen, A. S. and Simms, R. W. (1994). Autonomic neuropathy in AL (primary) amyloidosis and its effect on survival. Amyloid-Inter. J. Exp. Clin. Invest., 1, 39-46.
4. Bland, J. M. and Altman, D. G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 1, 307-310.
5. Brown, C. and Hanna, C. (1978). Use of dilute drug solutions for routine cycloplegia and mydriasis. Am. J. Ophthalmol., 86, 820-824.
6. Brown, R. H., Hotchkiss, M. L. and Davis, E. B. (1985). Creating smaller eyedrops by reducing eyedropper tip dimensions. Am. J. Ophthalmol., 99, 460-464.
7. Chrai, S. S., Makoid, M. C., Eriksen, S. P. and Robinson, J. R. (1974). Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. J. Pharm. Sci., 63, 333-338.
8. Craig, E. W. and Griffiths, P. G. (1991). Effect on mydriasis of modifying the volume of phenylephrine drops. Br. J. Ophthalmol., 75, 222-223.
9. Diehl, D. L. C., Robin, A. L. and Wand, M. (1991). The influence of iris pigmentation on the miotic effect of thymoxamine. Am. J. Ophthalmol., 111, 351-355.
10. Douglas, J. F., Gasiorek, J. M. and Swaffield, J. A. (1995). Fluid Mechanics, 3rd Edn. Longman Scientific and Technical, Harlow, England, pp. 808.
11. Emiru, V. P. (1971). Response to mydriatics in the African. Br. J. Ophthalmol., 55, 538-543.
12. Fell, J. T. (1988). Surface and interfacial phenomena. In: Pharmaceutics: The Science of Dosage Form Design (ed: M. E. Aulton) Churchill Livingstone, pp. 53-55.
13. Fraunfelder, F. T. (1989). Drug Induced Ocular Side Effects and Drug Interactions, 3rd edn. Lea & Febiger, Philadelphia/London, pp. 492-624.
14. Gentile, S., Marmo, R., Peduto, A., Montella, F. and Coltorti, M. (1994). Autonomic neuropathy in liver cirrhosis - relationship with alcoholic etiology and severity of the disease, Ital. J. Gastroent., 26, 53-58.
15. Green, K. (1992). The role of surfactants as bactericides in topical drug delivery. STP Pharm. Sci., 2, 34-38.
16. Halberg, G. P., Kelly, S. E. and Morrone, M. (1975). Drug delivery systems for topical ophthalmic medication. Ann. Ophthalmol., 7, 1199-1209.
17. Hreidarson, A. B. (1988). Reduced pupillary unrest: autonomic nervous system abnormality in Diabetes mellitus. Diabetes, 37, 446-451.
18. Ibrahim, H., Gurny, R., Buri, P., Ryser, J. E. and Donath, A. (1987). Evaluation of the precorneal residence time of a drug delivery system by gamma scintigraphy in rabbit. Proc. 3rd Eur. Congr. Biopharm. Pharmacokinetics, 1, 454-462.
19. Ismail, E. E., Rouse, M. W. and DeLand, P. N. (1994). A comparison of drop instillation and spray application of 1 % cyclopentolate hydrochloride. Optom. Vis. Sci., 71, 235-241.
20. Jauregui, M. J. and Polse, K. A. (1974). Mydriatic effect using phenylephrine and proparacaine. Am. J. Optom. Opt., 51, 545-549.
21. Kelly, J. A., Molyneux, P. D., Smith, S. A. and Smith, S. E. (1989). Relative bioavailability of pilocarpine from a novel ophthalmic delivery system and conventional eyedrop formulations. Br. J. Ophthalmol., 73, 360-362.
22. Keßler, C., Bleckmann, H. and Kleintges, G. (1991). Influence of the strength, drop size and viscosity of metipranolol eye drops on the concentration of the substance in human aqueous humour. Graefe 's Arch. Clin. Exp. Ophthalmol., 229, 452-456.
23. Kirvela, M., Ylihankala, A. and Lindgren, L. (1994). QT dispersion and autonomic function in diabetic and nondiabetic patients with renal failure. Br. J. Anaesthesia, 73, 801-804.
24. Korczyn, A. D. (1975). Adrenergic denervation supersensitivity. Adv. Neurol., 9, 113-120.
25. Liote, F. and Osterland, C. K. (1994). Autonomic neuropathy in systemic lupus erythematosus - cardiovascular autonomic function assessment. Ann. Rheum. Disease, 53, 671-674.
26. Loewenstein, A., Bolocinic, S., Goldstein, M. and Lazar, M. (1994). Application of eye drops to the medial canthus. Graefe's Arch. Clin. Exp. Ophthalmol., 232, 680-682.
27. Lovasik, J. V. and Kergoat, H. (1990). Time course of cycloplegia induced by a new phenylephrine-tropicamide combination drug. Optom. Vis. Sci., 67, 352-358.
28. Ludwig, A. and Van Ooteghem, M. (1988). Influence of the surface tension of eye drops on the retention of a tracer in the precorneal area of human eyes. J. Pharm. Belg., 43, 157-162.
29. Lundvall, A. and Zetterstrom, C. (1993). Exfoliation syndrome and the effect of phenylephrine and pilocarpine on pupil size. Acta Ophthalmol., 71, 177-180.
30. Maclean, H. and Dhillon, B. (1993). Pupil cycle time and human-immunodeficiency-virus (HIV) infection. Eye, 7, 785-786.
31. Maillot, F., Goupille, P., Vedere, V. and Valat, J. P. (1993). Peripheral neuropathies in rheumatoid arthritis. Sem. des Hopit., 69, 545-549.
32. Mansour, A. M. (1991). Tolerance to topical preparations: cold or warm? Ann. Ophthalmol., 23, 21-22.
33. Mapstone, R. and Clark, C. V. (1985). The prevalence of autonomic neuropathy in glaucoma. Trans. Ophthalmol. Soc. (UK), 104, 265-269.
34. McCormack, D. L. (1990). Reduced mydriasis from repeated doses of tropicamide and cyclopentolate. Ophthalmic Surg., 21, 508-512.
35. Nishizawa, A. R., Orton, R. B. and Cadera, W. (1988). Comparison of 0.5% cyclopentolate plus 0.5% tropicamide and 1 % cyclopentolate alone for mydriasis of dark irides. Can. J. Ophthalmol., 23, 299-300.
36. Norn, M. S. (1988). Tear fluid pH in normals, contact lens wearers and pathological cases. Acta Ophthalmol., 66, 485-489.
37. Patil, P. N. and Jacobowitz, D. (1974). Unequal accumulation of adrenergic drugs by pigmented and nonpigmented irides. Am. J. Ophthalmol., 78, 470-477.
38. Patton, T. F. (1977). Pharmacokinetic evidence for improved ophthalmic drug delivery by reduction of instilled volume. J. Pharm. Sci., 66, 1058-1059.
39. Stolovitch, C., Alster, Y., Loewenstein, A. and Lazar, M. (1994). Influence of the time interval between instillation of two drops of cyclopentolate 1 % on refraction and dilation of the pupil in children. Am. J. Ophthalmol., 119, 637-639.
40. Talks, S. J., Tsaloumas, M., Missom, G. P. and Gibson, J. M. (1993). Angle closure glaucoma and diagnostic mydriasis. Lancet, 342, 1493-1494.
41. Wheatcroft, S., Sharma, A. and McAllister, J. (1993). Reduction in mydriatic drop size in premature infants. Br. J. Ophthalmol., 77, 364-365.